The full PHARMAC notification of changes to the National Immunisation Schedule is available on the PHARMAC website www.pharmac.govt.nz under News/Notifications. The following details have been taken directly from page one of the
From 1 January 2017
Human papillomavirus (HPV) vaccine
- Funded access will be widened to include people up to the age of 26 years.
- A two-dose regimen will be funded for those children aged 14 years and under.
- The two-dose regimen was recently approved by Medsafe.
- A three-dose schedule will be funded for people aged 15-26 years inclusive.
- The 4 valent (Gardasil) HPV vaccine will be replaced with the 9 valent (Gardasil 9) vaccine.
- Females who have started a three-dose regimen of 4 valent Gardasil will be able to complete their remaining doses in 2017.
From 1 July 2017
- Funded access of the varicella vaccine (Varilrix) will be widened to include one dose for primary vaccination in children at 15 months old and a catch up in general practice of one dose for previously unvaccinated children at 11 years old, who have not previously had a varicella infection (chickenpox).
- Funding criteria for high risk patients will remain unchanged.
- There will be a change in pack size from 1 to 10 injections per pack.
Pneumococcal conjugated vaccine (PCV)
- The 13 valent (Prevenar 13) PCV13 pneumococcal vaccine will be replaced by the 10 valent (Synflorix) PCV10 vaccine on the National Immunisation Schedule.
- Prevenar 13 will remain available for high risk patients only.
- The currently listed RotaTeq brand will be replaced by the Rotarix brand.
- The current three-dose regimen will be replaced with a two-dose regimen.
Measles, mumps and rubella vaccine
- The currently listed MMR-II brand will be replaced by the Priorix brand.
Haemophilus influenzae type b (Hib) vaccine
- The currently listed Act-HIB brand will be replaced by the Hiberix brand.
No changes to the following listed vaccines
- Diphtheria, tetanus and acellular pertussis vaccine (Boostrix);
- Diphtheria, tetanus, acellular pertussis and polio vaccine (Infanrix IPV);
- Diphtheria, tetanus, pertussis, polio, haemophilus influenzae type b and hepatitis B vaccine (Infanrix Hexa); and
- Adult diphtheria and tetanus vaccine (ADT Booster).